Martifer SGPS, S.A. (LON:0GOI)
2.510
+0.010 (0.40%)
At close: Dec 4, 2025
Martifer SGPS Revenue
Martifer SGPS had revenue of 137.16M EUR in the half year ending June 30, 2025, with 34.97% growth. This brings the company's revenue in the last twelve months to 270.74M, up 16.07% year-over-year. In the year 2024, Martifer SGPS had annual revenue of 256.18M with 20.68% growth.
Revenue (ttm)
270.74M EUR
Revenue Growth
+16.07%
P/S Ratio
0.91
Revenue / Employee
165.59K EUR
Employees
1,635
Market Cap
210.10M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 256.18M | 43.90M | 20.68% |
| Dec 31, 2023 | 212.28M | 20.22M | 10.53% |
| Dec 31, 2022 | 192.06M | -20.07M | -9.46% |
| Dec 31, 2021 | 212.13M | -15.11M | -6.65% |
| Dec 31, 2020 | 227.24M | -9.67M | -4.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |